Compare

Compare stocks side by side

Pick up to 3 companies to see where each one is stronger or weaker.

LUNGBSX

Pulmonx Corporation

LUNG · $1.83

42Weak

Boston Scientific Corporation

BSX · $45.69

69Good

Area by area

Overall Quant Score

How does it look overall? (out of 100)

LUNG

42/100

BSX

69/100

Quality

Is it a profitable, well-run business?

LUNG

2.0/10

BSX

5.5/10

Growth

Is the company growing?

LUNG

4.3/10

BSX

6.6/10

Valuation

Is the price reasonable? (higher = cheaper)

LUNG

0.0/10

BSX

9.1/10

Risk

How risky are the shares? (higher = lower risk)

LUNG

5.0/10

BSX

4.9/10

Momentum

Is the share price trending up?

LUNG

7.5/10

BSX

7.3/10

Financial strength

Is the balance sheet healthy?

LUNG

2.9/10

BSX

5.8/10

The balanced view

Model-generated

Pulmonx Corporation

This company scores below average, with a positive price trend, although its current valuation deserves attention.

Leads on: risk, momentum

Best feature: positive price trend (RSI (14): 46.7)

Watch out: valuation may be demanding (P/E (TTM): -1.6x)

Boston Scientific Corporation

This company scores above average, with a reasonable valuation and a positive price trend.

Leads on: quality, growth, valuation, financial strength

Best feature: reasonable valuation (PEG: 0.40)

Watch out: weakest area: risk profile (Largest 1Y drawdown: -60%)

Different strengths suit different goals — a higher score in one area doesn’t make a stock the better choice for everyone.